Phenominer Database Results (7 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 63 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 427 days 6 158.33 null 4.59 11.24 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 371 days 100789 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 308 days) then enalapril (15 mg/l) (for 175 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 364 days 6 201.08 null 15.0 36.74 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 308 days 100778 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 427 days 6 179.66 null 2.47 6.05 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 371 days 100791 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 175 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 364 days 6 182.12 null 13.44 32.92 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 308 days 100777 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 427 days 6 178.53 null 22.47 55.04 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 371 days 100790 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) and anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 427 days 6 201.84 null 11.34 27.78 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 371 days 100792 2522
Crl:SD number of podocytes per kidney glomerulus streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 175 days) Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 364 days 6 158.59 null 4.58 11.22 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 stz 308 days 100776 2522